Genetic Analysis

Kids First Releases Datasets to Advance Pediatric Genetic Research
Research & Development Kids First Releases Datasets to Advance Pediatric Genetic Research

In a significant step toward understanding and combating childhood cancers and congenital disorders, the Gabriella Miller Kids First Pediatric Research Program (Kids First), an initiative of the National Institutes of Health (NIH), has released two comprehensive new datasets. Focusing on childhood

Sangamo's Gene Therapy Shows Promise for Fabry Disease Treatment
Research & Development Sangamo's Gene Therapy Shows Promise for Fabry Disease Treatment

Sangamo Therapeutics, Inc., a leading genomic medicine company, has reported promising updated data from the Phase 1/2 STAAR study. This study explores the efficacy of isaralgagene civaparvovec (ST-920) as a treatment for Fabry disease. The analysis, which reflects data up to September 12, 2024,

Why is Rentschler Exiting the Cell and Gene Therapy Market?
Research & Development Why is Rentschler Exiting the Cell and Gene Therapy Market?

In a surprising move, Rentschler Biopharma announced its decision to withdraw from the cell and gene therapy (CGT) business at its Stevenage, UK facility, marking a significant shift in the company's strategic focus. This decision comes despite recent investments in building advanced

New Study Disputes Link Between Maternal Health and Autism Risk
Research & Development New Study Disputes Link Between Maternal Health and Autism Risk

A recent study conducted by researchers at NYU Langone Health has reexamined the purported link between a mother’s health during pregnancy and the likelihood of her child developing autism. This study disputes previous assertions that maternal health conditions during pregnancy contribute directly t

Developmental Epigenetics Unveiled as Key Factor in Lifetime Cancer Risk
Research & Development Developmental Epigenetics Unveiled as Key Factor in Lifetime Cancer Risk

The groundbreaking research conducted by Van Andel Institute scientists sheds new light on how developmental epigenetic changes can profoundly influence cancer risk later in life. The study, published in Nature Cancer, identifies two distinct epigenetic states formed during development, which are

Is the NHS BRCA Testing Program a Breakthrough for Jewish Health?
Tech & Innovation Is the NHS BRCA Testing Program a Breakthrough for Jewish Health?

The NHS BRCA Testing Program launched in January 2023 has been a significant success in England, offering free genetic testing to individuals with Jewish ancestry to identify their risk of inherited cancers. This initiative targets people aged 18 or over with at least one Jewish grandparent, and it

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later